When celebrities publicly share their cancer diagnoses, it is common for medical professionals to experience dramatic increases in office calls and for Internet searches about the celebrity’s cancer to rise. In this blog post, we shine the spotlight on a few...
Sue Friedman is the Founder and the Executive Director of FORCE: Facing Our Risk of Cancer Empowered, a national non-profit organization dedicated to improving the lives of those with hereditary breast, ovarian, and related cancers. Sue has been a well-known leader in...
Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...
Since its launch in 2013, ClinVar has not only amassed a wealth of genetic variant information, but the lab and clinical genetics community in the US are readily referencing it when they have questions about the clinical significance of variants. A few healthcare...
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...